Wolverine Trading’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Wolverine Trading’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-18,460	Closed	-$311K	–	5453
2019 Q3	$257K	Sell	18,460 -200	-1%	-$2.37K	﹤0.01%	3324
2019 Q2	$230K	Buy	+18,660	New	+$215K	﹤0.01%	3560
2019 Q1	–	Sell	-35,523	Closed	-$475K	–	5606
2018 Q4	$422K	Buy	+35,523	New	+$557K	﹤0.01%	2812
2018 Q3	–	Sell	-16,915	Closed	-$389K	–	6227
2018 Q2	$379K	Hold	16,915	–	–	﹤0.01%	3439
2018 Q1	$379K	Buy	16,915 +3,299	+24%	+$80.5K	﹤0.01%	3439
2017 Q4	$341K	Sell	13,616 -706	-5%	-$17.3K	﹤0.01%	3450
2017 Q3	$346K	Buy	+14,322	New	+$337K	﹤0.01%	3075
2017 Q2	–	Sell	-7,867	Closed	-$164K	–	5216
2017 Q1	$213K	Buy	+7,867	New	+$161K	﹤0.01%	3455

Wolverine Trading's FLXN Position: Q4 2019 in Review

Wolverine Trading sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2019, closing a stake of 18,460 shares — an estimated $311K sold.

Wolverine Trading first reported a position in FLXN in Q1 2017 and held it in 8 quarters. The position peaked at $422K in Q4 2018. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.

Wolverine Trading reported no remaining Flexion Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
Wolverine Trading sold 18,460 Flexion Therapeutics, Inc. shares in Q4 2019, an estimated $311K.
Wolverine Trading first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 8 quarters.
Wolverine Trading's Flexion Therapeutics, Inc. position peaked at $422K in Q4 2018.
133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.